FDA Watch: AI-Based Sepsis Prediction Test Receives FDA Authorization
Prenosis claims its test can detect the presence of the often deadly condition within 24 hours of a hospitalization
Author Information
Prenosis claims its test can detect the presence of the often deadly condition within 24 hours of a hospitalization
Recently announced collaboration between Viome and Henry Schein allows dentists to offer sample collection for Viome’s assay to patients
Though not expected to drastically change the program, new component gives device makers another way to strengthen their submissions
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
The ALZpath DX assay is less invasive than other diagnostic tests, and may give patients diagnosed with Alzheimer’s more time to plan
The FDA is adding International Organization for Standardization (ISO) guidelines to its “good manufacturing” requirements
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
Both companies have made recent moves to diversify further.
Such assays rely more on imaging and computer power than tissue samples to make diagnoses.
Whether the MiniDraw™ device dredges up memories of Theranos’ failed tech remains to be seen.